U.S. NeuroSurgical Holdings, Inc.

USNU · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$2,055-$816-$1,572-$674
Dep. & Amort.$13$20$39$35
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$5$0$0
Change in WC$93-$98-$322$343
Other Non-Cash$434-$2$442$470
Operating Cash Flow-$1,515-$891-$1,413$174
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$746-$491
Inv. Sales/Matur.$0$355$1,518$22
Other Inv. Act.$263-$535$0$532
Investing Cash Flow$263-$180$772$63
Financing Activities
Debt Repay.$0$0$0-$89
Stock Issued$5,175$0$0$0
Stock Repurch.-$355$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$4,820$0$0-$89
Forex Effect$0$0$0$0
Net Chg. in Cash$3,568-$1,071-$641$148
Supplemental Information
Beg. Cash$466$1,537$2,178$2,030
End Cash$4,034$466$1,537$2,178
Free Cash Flow-$1,515-$891-$2,185$174
U.S. NeuroSurgical Holdings, Inc. (USNU) Financial Statements & Key Stats | AlphaPilot